ES2180625T3 - Derivados de camptotecina solubles en agua, proceso para su preparacion y su uso como agentes antitumorales. - Google Patents
Derivados de camptotecina solubles en agua, proceso para su preparacion y su uso como agentes antitumorales.Info
- Publication number
- ES2180625T3 ES2180625T3 ES95908901T ES95908901T ES2180625T3 ES 2180625 T3 ES2180625 T3 ES 2180625T3 ES 95908901 T ES95908901 T ES 95908901T ES 95908901 T ES95908901 T ES 95908901T ES 2180625 T3 ES2180625 T3 ES 2180625T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- derivatives
- rent
- pharmacologically acceptable
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE LA CAMPTOTECINA DE LA FORMULA (I) EN DONDE B ES UN GRUPO B'' O B" EN DONDE CADA UNA DE (X) E (Y) ES UN ENLACE SIMPLE O DOBLE, R1 Y R2 SON CADA INDEPENDIENTEMENTE HIDROGENO, ALQUIL C{SUB, 1-6}, CICLOALQUIL C{SUB, 3-7}, FENILALQUIL C{SUB, 1-6} O UN ANILLO DE FENIL SUSTITUIDO O INSUSTITUIDO, R3 Y R4 SON (A) CADA UNA INDEPENDIENTEMENTE SUSTITUYENTES QUE TIENEN LOS MISMOS SIGNIFICADOS DE R1 Y R2 O (B) COMBINADAS ENTRE SI CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDAS FORMAN UN ANILLO HETEROMONOCICLICO SUSTITUIDO O INSUSTITUIDO, SATURADO DE ENTRE 3 Y 7 MIEMBROS, QUE PUEDE ADICIONALMENTE CONTENER OTRO HETEROATOMO SELECCIONADO ENTRE NITROGENO, OXIGENO Y AZUFRE, Y A ES UN ANION FARMACOLOGICAMENTE ACEPTABLE DE UN ACIDO ORGANICO O INORGANICO FARMACOLOGICAMENTE ACEPTABLE, TENIENDO EN CUENTA QUE (I) CUANDO (X) ES UN ENLACE DOBLE, (Y) ES UN ENLACE SIMPLE Y CUANDO (Y) ES UN ENLACE DOBLE, (X) ES UN ENLACE SIMPLE, Y (II) CUANDO B ES UN GRUPO B'', ENTONCES UNA DE R2, R3 Y R4 ESTA AUSENTE; R6 ES HIDROGENO O ALQUIL C{SUB, 1-6}, X ES HIDROGENO, ALQUIL C{SUB, 1-6}, ALCOXIDO C{SUB, 1-6}, ACILOXIDO C{SUB, 1-6}, CICLOALQUIL C{SUB, 3-7}, BENZOILOXIDO, AMINO, HIDROXIDO, NITRO, UN ATOMO DE HALOGENO O UN GRUPO DE METILENODIOXIDO UNIDO A LA POSICION 10 Y 11 DE LA MOLECULA. TAMBIEN SE PRESENTAN LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS DERIVADOS. LOS DERIVADOS DE LA CAMPTOTECINA DE LA INVENCION SON UTILES EN TERAPIAS COMO AGENTES ANTITUMORALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9402934A GB9402934D0 (en) | 1994-02-16 | 1994-02-16 | Camptothecin derivatives and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180625T3 true ES2180625T3 (es) | 2003-02-16 |
Family
ID=10750430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95908901T Expired - Lifetime ES2180625T3 (es) | 1994-02-16 | 1995-02-03 | Derivados de camptotecina solubles en agua, proceso para su preparacion y su uso como agentes antitumorales. |
Country Status (20)
Country | Link |
---|---|
US (2) | US5602141A (es) |
EP (1) | EP0694035B1 (es) |
JP (1) | JPH08509244A (es) |
KR (1) | KR960701878A (es) |
CN (1) | CN1123548A (es) |
AT (1) | ATE220681T1 (es) |
AU (1) | AU681941B2 (es) |
CA (1) | CA2158855C (es) |
DE (1) | DE69527400T2 (es) |
ES (1) | ES2180625T3 (es) |
FI (1) | FI954898A0 (es) |
GB (1) | GB9402934D0 (es) |
HU (1) | HUT73423A (es) |
IL (1) | IL112622A (es) |
MX (1) | MX9504287A (es) |
NO (1) | NO954072L (es) |
NZ (1) | NZ279813A (es) |
PL (1) | PL311122A1 (es) |
WO (1) | WO1995022549A1 (es) |
ZA (1) | ZA951227B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9319944D0 (en) * | 1993-09-28 | 1993-11-17 | Erba Carlo Spa | Process for the preparation of 9-amino camptothecin |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
GB9410388D0 (en) * | 1994-05-24 | 1994-07-13 | Erba Carlo Spa | Method for the preparation of 9-amino camptothecin |
GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
GB9601779D0 (en) * | 1996-01-30 | 1996-04-03 | Pharmacia Spa | 9, 10 Disubstituted camptothecin derivatives |
US6096336A (en) * | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
GB9702807D0 (en) | 1997-02-12 | 1997-04-02 | Pharmacia & Upjohn Spa | Alkynyl-substituted camptothecins and process for their preparation |
GB9715821D0 (en) * | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
US6043367A (en) * | 1998-09-30 | 2000-03-28 | Roffler; Steve | Proactive antitumor compounds |
US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
IL162058A0 (en) | 2001-11-30 | 2005-11-20 | Chugai Pharmaceutical Co Ltd | Hexacyclic compounds |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
CZ299329B6 (cs) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu |
CZ299593B6 (cs) * | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
CA2563502A1 (en) | 2004-04-09 | 2005-10-20 | Chugai Seiyaku Kabushiki Kaisha | Novel water-soluble prodrug |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
JP5126900B2 (ja) * | 2009-02-24 | 2013-01-23 | 株式会社渡辺オイスター研究所 | カキ肉エキス顆粒の製造方法。 |
CN101555250B (zh) * | 2009-05-19 | 2011-05-18 | 重庆泰濠制药有限公司 | 盐酸拓扑替康的制备方法 |
WO2022246576A1 (en) * | 2021-05-27 | 2022-12-01 | Zymeworks Inc. | Camptothecin analogues, conjugates and methods of use |
WO2023061393A1 (zh) | 2021-10-15 | 2023-04-20 | 昆山新蕴达生物科技有限公司 | 包含抗肿瘤药物的组合物及其制备方法和用途 |
WO2023178452A1 (en) * | 2022-03-25 | 2023-09-28 | Zymeworks Bc Inc. | Antibody-drug conjugates targeting folate receptor alpha and methods of use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
US4981968A (en) * | 1987-03-31 | 1991-01-01 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US5227380A (en) * | 1987-03-31 | 1993-07-13 | Research Triangle Institute | Pharmaceutical compositions and methods employing camptothecins |
US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5180722A (en) * | 1987-04-14 | 1993-01-19 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
NZ235329A (en) * | 1989-09-15 | 1992-01-29 | Res Triangle Inst | 20(s or rs)-camptothecin derivatives and pharmaceutical compositions |
WO1991004260A2 (en) * | 1989-09-15 | 1991-04-04 | Research Triangle Institute | 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs |
SK283693B6 (sk) * | 1990-09-28 | 2003-12-02 | Smithkline Beecham Corporation | Spôsob prípravy kamptotecínu alebo jeho farmaceuticky prijateľnej soli |
US5162532A (en) * | 1990-12-20 | 1992-11-10 | North Carolina State University | Intermediates and method of making camptothecin and camptothecin analogs |
US5342947A (en) * | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
-
1994
- 1994-02-16 GB GB9402934A patent/GB9402934D0/en active Pending
-
1995
- 1995-02-03 CN CN95190093A patent/CN1123548A/zh active Pending
- 1995-02-03 HU HU9503273A patent/HUT73423A/hu unknown
- 1995-02-03 CA CA002158855A patent/CA2158855C/en not_active Expired - Fee Related
- 1995-02-03 MX MX9504287A patent/MX9504287A/es unknown
- 1995-02-03 WO PCT/EP1995/000393 patent/WO1995022549A1/en active IP Right Grant
- 1995-02-03 ES ES95908901T patent/ES2180625T3/es not_active Expired - Lifetime
- 1995-02-03 DE DE69527400T patent/DE69527400T2/de not_active Expired - Fee Related
- 1995-02-03 AT AT95908901T patent/ATE220681T1/de active
- 1995-02-03 PL PL95311122A patent/PL311122A1/xx unknown
- 1995-02-03 EP EP95908901A patent/EP0694035B1/en not_active Expired - Lifetime
- 1995-02-03 NZ NZ279813A patent/NZ279813A/en unknown
- 1995-02-03 AU AU17056/95A patent/AU681941B2/en not_active Ceased
- 1995-02-03 JP JP7521541A patent/JPH08509244A/ja not_active Ceased
- 1995-02-03 KR KR1019950704455A patent/KR960701878A/ko not_active Application Discontinuation
- 1995-02-13 IL IL112622A patent/IL112622A/xx not_active IP Right Cessation
- 1995-02-15 US US08/389,190 patent/US5602141A/en not_active Expired - Fee Related
- 1995-02-15 ZA ZA951227A patent/ZA951227B/xx unknown
- 1995-10-13 FI FI954898A patent/FI954898A0/fi not_active Application Discontinuation
- 1995-10-13 NO NO954072A patent/NO954072L/no unknown
-
1996
- 1996-08-20 US US08/697,125 patent/US5801167A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL311122A1 (en) | 1996-02-05 |
DE69527400D1 (de) | 2002-08-22 |
EP0694035A1 (en) | 1996-01-31 |
FI954898A (fi) | 1995-10-13 |
IL112622A0 (en) | 1995-05-26 |
ZA951227B (en) | 1996-01-19 |
US5602141A (en) | 1997-02-11 |
FI954898A0 (fi) | 1995-10-13 |
CN1123548A (zh) | 1996-05-29 |
JPH08509244A (ja) | 1996-10-01 |
GB9402934D0 (en) | 1994-04-06 |
KR960701878A (ko) | 1996-03-28 |
ATE220681T1 (de) | 2002-08-15 |
CA2158855A1 (en) | 1995-08-24 |
DE69527400T2 (de) | 2003-03-06 |
AU1705695A (en) | 1995-09-04 |
NO954072D0 (no) | 1995-10-13 |
AU681941B2 (en) | 1997-09-11 |
MX9504287A (es) | 1997-05-31 |
US5801167A (en) | 1998-09-01 |
WO1995022549A1 (en) | 1995-08-24 |
NO954072L (no) | 1995-12-11 |
IL112622A (en) | 1997-09-30 |
EP0694035B1 (en) | 2002-07-17 |
HU9503273D0 (en) | 1996-01-29 |
NZ279813A (en) | 1996-10-28 |
HUT73423A (en) | 1996-07-29 |
CA2158855C (en) | 2006-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180625T3 (es) | Derivados de camptotecina solubles en agua, proceso para su preparacion y su uso como agentes antitumorales. | |
ES2221440T3 (es) | Derivados de acido aminofenoxiacetico como neuroprotectores. | |
GT199800180A (es) | Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos. | |
ES2043625T3 (es) | Derivados de acido ariloxicarboxilico, su preparacion y empleo. | |
CY1106375T1 (el) | Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας | |
PE20021019A1 (es) | Grupos azabiciclicos sustituidos | |
AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
AR023971A1 (es) | Derivados de 4,5,6,7-tetrahidroindazol, procedimiento para la preparacion de los mismos y su utilizacion como agentes antitumorales | |
ATE448226T1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
ES2187814T3 (es) | Derivados de pirazolopiridinopiridazinonas y procedimiento para su preparacion. | |
HN1999000149A (es) | Derivados de 4,4-biarilpiperidina | |
DOP2001000170A (es) | Derivados de tiofeno utiles como agentes anticancesoros | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
AR009938A1 (es) | Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos | |
ES2178632T3 (es) | Compuestos de benzoquinazolina farmaceuticamente activos. | |
AR012870A1 (es) | Derivados de ergolina ([6ar, 9r, 10ar]-6-[4-(5-bromo-7-metil-4,6,6a,7,8,9, 10,10a-octahidro-indol[4,3-fg]quinolin-9-carbonil)-piperazin-1-il]-1-metil-1h-piridin-2-ona), proceso para su produccion, composicion farmaceutica, y su uso para la fabricacion de un medicamento para el tratamiento de depresi | |
ES2178205T3 (es) | Compuestos amida indazol como agentes serotoninergicos. | |
NO20000737L (no) | Tetrahydro <gamma>-karboliner | |
BR9714215A (pt) | Derivados de benzoato de 1,4-diazabiciclo[2.2.2]oct-2-ilmetila, seu preparo e sua aplicação em terapêutica | |
ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
SE7708029L (sv) | Forfarande for framstellning av nya pyridinderivat | |
ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
ES2061530T3 (es) | 9-amino-1,4-etano-1,2,3,4-tetrahidroacridina y compuestos afines, intermediarios y un procedimiento para la preparacion de los mismos y su uso como medicamentos. | |
UY27001A1 (es) | Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos |